Facilities for Personalised Medicine in the Most Personal Form – Today and Tomorrow

When redoing the batch is not an option There is a paradigm shift underway in which big pharma mass production of products for specific diseases is deviating towards the ‘batch of one.’ These autologous therapies are patient-specific and there may only be one chance to harvest the patient’s ce...

To read the full article and other articles in this issue, please register for an account or log in.

We will not sell your information to a third party. See our Privacy Policy



Subscribe to our FREE newsletter